Brief introduction: Hubei Biomedical Industry Technology Research Institute Co., Ltd., founded on April 25th, 2004, is located in Wuhan Optics Valley Biological City. The company is committed to the research and development and industrialization of innovative drugs such as biological drugs, chemical drugs and traditional Chinese medicine, and builds an international service platform for the industrialization of innovative drugs. The company takes "enterprise as the main body and market as the guidance", uses innovative systems and mechanisms, gathers all kinds of resources, takes the industrialization of pharmaceutical innovation as the guidance, and focuses on providing professional services for the innovation and creation of new drugs. The company can provide professional technical consultation and registration services for the project, including project evaluation, planning, design, technology and key nodes in the R&D process. The service scope includes all aspects of new drug creation from research and development to industrialization, providing professional services covering the whole industrial chain for new drug innovation and creation, helping to improve the research and development efficiency of the project and accelerate the development and industrialization of the project. 1. Genetic engineering drug development and production platform 2. Purification and separation technology of drug impurities. Research technology of pharmaceutical crystals. There are 5 key technical platforms for separation and purification of macroporous adsorption resin. Supercritical extraction and purification platform 6. Nano-preparation technology service platform. Drug delivery system platform 8. Drug quality research and standard setting. Pilot service unit 10. Clinical service unit 1 1. Compile the research service module 12. Register the service unit 13. International cooperation service unit 1. Mission: To enable patients in China to enjoy world-class new drug services at reasonable prices, and actively promote the industrial transfer of innovative drugs from laboratories to markets. 2. Vision: To build an internationally renowned and domestic first-class platform for the industrialization of innovative drugs. 3. Core spiritual science innovation: seeking truth from facts and sincere service cooperation.
Legal Representative: Jie Shen.
Establishment time: 20 14-04-25
Registered capital: 265,438 yuan+0,457,954.38 yuan+0,970 yuan.
Industrial and commercial registration number: 42000000054277
Type of enterprise: other limited liability companies
Company address: Room 2 17, Building C7, No.666 Gaoxin Avenue, Donghu High-tech Zone, Wuhan.